Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 10, 2021 11:34am
116 Views
Post# 32525508

RE:RE:Just added to my position....SZLS

RE:RE:Just added to my position....SZLSProblem is that other than attending a couple conferences we haven't had an updated since early December when he discussed Q3 results.

Now I'm not saying we need press releases monthly but this has been the most unique and exciting times in the company's history. In  under 6 weeks they plan to announce Aristotle and the opporunity for Covid revenue keeps increasing, we have new instititional investors and doubling the size of the lab.  

You would think that giving these exciting times some additional updates would be warranted.  Instead they go radio silent.  I don't agree with that strategy.  I mentioned momentum before.  Other stocks are reaching new highs on less opportunity and less revenue, yet szls is silent.  I don't thibk Tripp puts himself in investors shoes or understands the need to keep shareholders informed.  How does he think he will ever achieve Nasdaq without building momentum and trust.

We are on the brink of a major sea change with this company and they are choosing to stay silent.  It makes no sense.

I will continue to hold as I have for years but I do shake my head over how Tripp and Rebecca are playing this.


capebretongirl wrote:
Oilersgoforcup wrote: Took another 15000 at $1.08....big guys shaking the tree....buy time.....news just around the corner....good luck to all !!!



Its hard to believe people sell this at $1.08 as we sit on the cusp of a major NR and roll out of a technology 18 years in the making.  Do they really think they will be able to buy back in at $1.07 when that day comes? Over $7 mil in the bank, millions of revenue per quarter, collaborations being made and an awareness like never before adds up to some wonderful developments in the immediate future!!! GLTA.


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse